Salix Pharmaceuticals, Ltd. Stockholders Encouraged to Contact Securities Law Firm about Takeover

NEW YORK, Feb. 27, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Salix Pharmaceuticals, Ltd. SLXP in connection with a buyout for only $158.00 per share. Concerned SLXP investors are encouraged to contact attorney Hamilton Lindley by clicking here.

The investigation focuses upon the shareholder value of the transaction. Under terms of the proposed agreement, Salix shareholders would receive only $158.00 per share in cash. At least one analyst has set a target price of $185.00. The firm's potential shareholder lawsuit will seek to obtain the highest price reasonably available and that all important information about the deal is disclosed.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. SLXP stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/SLXP.

Dunnam & Dunnam also practices personal injury law including Waco car accidents and Waco truck accidents.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/salix-pharmaceuticals-ltd-stockholders-encouraged-to-contact-securities-law-firm-about-takeover-300042807.html

SOURCE Dunnam & Dunnam